Suchergebnisse

The discipline of disaster medicine is the study and collaborative application of various health sciences towards the prevention of, preparation for, response to and recovery from health problems arising from a disaster. Because disasters can strike anywhere in the world and can have devastating effects on the community, it is vitally important that the different agencies, government departments and medical disciplines work together to draw up adequate mitigation plans. It is also crucial that each agency is aware of its responsibilities and understands the chain of command in a disaster situation.

Medicine use in pregnancy is extremely common, but there are significant knowledge gaps surrounding the safety, dosage and long-term effects of drugs used. Pregnant women have been purposively excluded from clinical trials of the majority of treatments for conditions that may occur concurrently with pregnancy. There is minimal information on the pharmacokinetics of many existing treatments, and no systematic capture of long-term outcome data to help inform choices. Treatments commonly used in pregnancy are thus often old and untested, not optimised in dose, and prescribed off-label without adequate safety information. In addition, there has been a staggering lack of investment in drug development for obstetric conditions for decades. This is a major public health concern, with pregnancy complications the leading cause of mortality in children under five years old globally, and health in pregnancy a major determinant of women's long-term health and wellbeing. There is an acute need for adequate investment and legislation to boost inclusion of pregnant women in clinical studies, capture high-quality information on medication use in pregnancy in general, and encourage new medicinal product development for obstetric conditions.

General issues -- Critical care medicine -- Medical consultation -- Cardiology -- Vascular medicine -- Pulmonary -- Infectious diseases -- Hiv disease -- Gastroenterology -- Hematology - oncology -- Renal -- Endocrinology -- Rheumatology -- Neurology and psychology -- Toxicology and allergy

The concept of 'evidence-based medicine' dates back to mid-19th century or even earlier. It remains pivotal in planning, funding and in delivering the health care. Clinicians, public health practitioners, health commissioners/purchasers, health planners, politicians and public seek formal 'evidence' in approving any form of health care provision. Essentially 'evidence-based medicine' aims at the conscientious, explicit and judicious use of the current best evidence in making decisions about the care of individual patients. It is in fact the 'personalised medicine' in practice. Since the completion of the human genome project and the rapid accumulation of huge amount of data, scientists and physicians alike are excited on the prospect of 'personalised health care' based on individual's genotype and phenotype. The first decade of the new millennium now witnesses the transition from 'evidence-based medicine' to the 'genomic medicine'. The practice of medicine, including health promotion and prevention of disease, stands now at a wide-open road as the scientific and medical community embraces itself with the rapidly expanding and revolutionising field of genomic medicine. This article reviews the rapid transformation of modern medicine from the 'evidence-based medicine' to 'genomic medicine'.

The world of sports medicine faces unique medical ethics issues. In this issue articles will include: Fundamental Ethical Principles in Sports Medicine, Confidentiality in Sports Medicine, Informed Consent in Sports Medicine, Conflicts of Interest in Sports Medicine, Performance enhancing drugs in sports medicine, Gene doping in sports medicine, Ethical considerations for analgesic use in sports medicine, and many more!

Stanisław Trzebiński (1861–1930), professor at Stefan Batory University in Vilnius, was one of the most distinguished representatives of the Polish School of Philosophy of Medicine before the Second World War. He undertook studies in neurology, philosophy of medicine, and literature.

The article explores Trzebiński's philosophical ideas, especially his call for rationality in medicine and the concept of absurdity in medicine as a precondition for the development of medical knowledge and practice. Today this method is an essential background in Evidence-Based Medicine and confirms cultural and scientific forms of cognition.

Abstract The intention of the researcher is to study about the generic medicines and the patented medicines. discusses about the history of patent laws in India, here she does a thorough study of how Indian laws have emerged to be progressive from the erstwhile British laws which did not foster growth and development in India. The researcher then proceeds to talk about the circumstances which led India to amend its Patents act of 1970 in 2005 and the effects of this amendment. Further the researcher focusses on the generic medicines where she talks about how they are manufactured and various factors of genetic medicine. The researcher then proceeds to clear various apprehensions and misconceptions with regard to generic medicines such as its quality and effectiveness and its low price factor in concern to its quality.Moves on to clear the dilemma of majority of Indians of choosing between the generic and patented medicines, here she details on their respective advantages and disadvantages for this purpose. To a name a few - The advantages of generic medicines are cheaper prices, easily available, Bioequivalent and so on while its disadvantages are it halts the innovation, not easy to spell or remember and son; The advantages of patented medicines are high efficiency, promote innovation and so on while its disadvantages areUnaffordability, supports monopolies. Importantly, the researcher deals with various judicial cases relating to IPR in India. Finally concludes this chapter stating that generic and patented medicines support the country in their own way.

Family physicians are naturally concerned with the work effects or causes of their patients' health problems. As occupational risk factors have become better understood, however, a new specialty of occupational medicine has been recognized by the Royal College of Physicians and Surgeons in 1984, two years after the Canadian Board of Occupational Medicine started its own certification. Occupational physicians are available to act as an extension of the family doctor's care and can provide trustworthy medical resources in the workplace. The family physician should be aware of some of the games poorly trained or ill-informed personnel managers may play in the workplace if they have no medical consultant to rely on. New human rights legislation has given more opportunities to rehabilitate workers back to their jobs, and occupational physicians and family physicians can achieve a great deal in co-operation as a result.

The issue of counterfeit medicines was mainly associated with developing countries, however it has now become of significant concern world-wide. While the exact extent of the problem is still unknown, the prevalence of counterfeit medicines is increasing, with a shift in focus from life style medicines to life saving medicines. As compared to 2005 the EU registered an increase of 380% of counterfeit medicines seized at EU borders in 2007. ; peer-reviewed